Successful surgery in patients with defective heemostasis is becoming possible and it is of interest to detail the problems encountered in nose and throat surgery.
Patients with a history of bleeding are being referred from various centres in the country to the Oxford Blood Coagulation Research Unit which is under the direction of Professor R G Macfarlane. Some of the cases belong to the specialty and the ENT Department of the Radcliffe Infirmary probably sees more than its share of patients with clotting defects. Surgery in this type of case can be undertaken in our department because of the facilities and specialist help available from the Unit but the time spent in the operating theatre is not necessarily the most important item in the management of a patient with a haemostatic defect. Detailed figures of the numbers of ENT cases will be given later; the average daily number of in-patients with defective heemostasis in various departments of the United Oxford Hospitals is about 14; sometimes there have been as many as 23 patients in at the same time. It is only because of the advice and help which I have received from Dr Rosemary Biggs and the staff of the Unit that it is possible to discuss such a highly specialized subject.
In the last ten years there have been advances in all branches of medicine: stapes surgery is an example in otology. In hematology the advances are second to none and they are still continuing. One textbook, published in 1953, states: '90% of haemophilics ... do not reach puberty. ' Biggs & Macfarlane (1953) state: 'The mortality of any major operation in haemophilics, even with massive transfusion therapy, is probably 50Y%.' Today on the other hand, any operation, however severe, is open to almost all himophilic patients but the reasons for surgery must always be carefully considered and all facets of the problem discussed and reviewed.
Mr A J Gunning, an erstwhile ENT surgeon, who is in Professor P R Allison's Department at Oxford, removed himophilic cysts in 6 patients with complete success. This original and pioneer surgery has probably never been attempted before; certainly such a large series has never before been completed successfully; it demonstrated dramatically the complete confidence the surgeon has in the ability of the hematologist to control the clotting of the blood and to keep it functioning, not only during the operation but also for as long after as is necessary to allow healing. The limbs were immobilized to prevent trauma and lessen the risk of additional bleeding. The series is unique.
Hwmostasis
In heemostasis the clotting process possibly appears simple but it is in fact very complicated and all the factors concerned have not yet been isolated. One more quotation, again from Biggs & Macfarlane (1953) , gives briefly a picture of what is entailed: 'The blood contains within itself not only the clotting factors that will initiate, accelerate and limit coagulation as required, but also a series of safety devices to prevent coagulation occurring within the vessels and for dissolving fibrin which is no longer useful.' Normal haemostasis can be visualized as being composed of two complementary stages, first the contraction of the small vessels and secondly the coagulation of the blood in the lumen of the vessels.
HAEMOSTATIC DEFECTS
Hemostatic defects can be divided into two main categories: (1) Capillary contraction defects.
(2) Coagulation defects.
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Capillary Defects In capillary bleeding, absent or defective contraction will allow immediate and continuing oozing from the small vessels.
Coagulation defects do not cause an immediate oozing: the bleeding occurs two to four hours later because, when the normal capillary contraction which causes the initial hwemostasis passes off, the lumen of the vessel is not filled with clot and bleeding starts again.
In patients with capillary defects the bleeding can be controlled by pressure at the site of operation: pressure will enable the normal blood to clot in the underlying vessels whereas the blood flow, if it is not stopped, will continuously wash away the forming clot; once a firm clot has been formed the bleeding does not restart. The management of capillary bleeding depends on getting the site of operation completely dry before the patient leaves the theatre, which requires patience; the wound, in severely affected cases, may require packing for-up to fifteen minutes. If this procedure is carried out conscientiously no trouble should be anticipated but, should the pressure be relaxed too soon, fresh bleeding will wash away the forming clot, so a further fifteen minutes may be required to allow a new clot to form.
Pressure, however, is of no avail to arrest bleeding which is due to coagulation defects. In the early days when surgery was attempted in cases of hemophilia, which is a blood-clotting disease and not a capillary defect, cauterization and tight packing were used, which merely enlarged the bleeding area and encouraged hematomata. The management of bleeding which is due to a coagulation defect depends on tracing the factor which is missing and replacing it in the circulation, not only at the time of operation but also throughout the period of healing.
Diagnosis
In order to separate cases into the two main groups of capillary bleeding and coagulation defects, it is necessary to take a full and careful history of any previous bleeding: this is the most important single investigation to ensure safe surgery, so surgeons should get as much information as possible when the patient is first seen in out-patients. This should include not only the patient's history but also the family history of bleeding; children alone are not a productive source of information and the background family history must be ascertained from an adult. One should be able to discriminate in out-patients between the two types of bleeding.
The signs and symptoms of the two groups are compared in Table 1 . If there is a conclusive story of a severe bleeding then it is essential that an accurate diagnosis is made and confirmed before any surgery is attempted. It is very difficult, indeed sometimes impossible, for a haematologist to make a diagnosis in a bleeding patient, who has had an operation and has already received several pints of blood. Table 2 shows the number of investigations carried out as a routine on these patients with a positive history of bleeding. This report was taken at random from a patient's notes.
By far the commonest of these hemostatic defects is a mild capillary bleeding tendency. The patient may report bleeding continuing for up to twenty-four hours after a dental extraction or persistent and troublesome nose bleeding. In the simple cases, laboratory tests reveal normal clotting; it is only the more seriously affected patients who show a long bleeding time or a positive tourniquet test. In mildly affected patients all the fourteen routine tests, if they are carried out, may be normal, the only indication of trouble being the patient's or family history.
Coagulation Defects
Coagulation defects are due to a deficiency in one of the factors concerned in the mechanism of clotting. There are thirteen recognized coagulation factors and deficiency of any one of ten of these may give rise to a bleeding tendency.
The modern theory of blood coagulation supposes a series of reactions between the different factors, the product of each reaction catalysing the next. Fig 1 shows how complicated and difficult the problem has become and the progress which has been made in separating the different stages.
The various coagulation factors are numbered so that hematologists in all countries can understand which phase or condition is being discussed.
Deficiencies of ten of these factors have been described and all of these give rise to clinical h,mmorrhagic states. In practice, however, 88 % of patients with coagulation defects are deficient in Factor VIII which is anti-htemophilic globulin (AHG). It is the discovery and isolation of AHG which has made most of this surgery possible. In 8 % of the patients the deficiency is of Factor IX; this clinical condition is called Christmas disease. The remaining 4 % include all the very rare deficiencies (Table 3) . As far as treatment is concerned all can be considered as deficiency states, in which the blood will clot normally if the missing factor can be replaced.
Replacement Therapy
The discovery of the various factors concerned in hemostasis and the preparation of them as stable and non-toxic replacement solutions are among the modern, very great advances in hematology. The general principle of treatment of patients with coagulation defects is the same regardless of the deficiency: it is that the missing factor must be replaced in the patient's circulation and the necessary concentration of it must be maintained until healing is well advanced. The ease of doing this varies from one defect to another and depends on the half-life of the infused material, that is the length of time the activity of the-factor remains in the circulation; it also depends on the potency of the preparation used. Some of the replacement infusions are in very short supply and are extremely difficult to prepare. It is also difficult to obtain solutions of sufficient concentration to allow the required blood levels to be maintained.
Ha-mophilia By far the commonest coagulation defect is deficiency in Factor VIII or anti-hiemophilic globulin. A short summary of heemophilia is necessary if the various problems are to be understood.
The incidence is about 2-3 per 100,000 of the population. It is a disease of Northern Europe and it has been reported chiefly among the Teutonic races; there are very few reports of its occurrence among Asiatic and Negro peoples. Apart from external bleeding or bleeding from the intestinal or renal tracts, there may be hemorrhage into the tissues following trauma or infection. Enormous hiematomata often result, which may interrupt the blood supply. Hemorrhage into the tissues of the neck or mediastinum used to be a cause of fatal asphyxia. Repeated himorrhage into the joints is one of the diagnostic criteria of the condition; this h2marthrosis produces great pain and swelling. Hemophilia is a sex-linked recessive condition affecting the male but being carried, by the female. When a, female carrier marries a normal male, 50% of their sons will be hemophilic and 50% of their daughters will be carriers. When a heemophilic male marries a normal female none of the sons will be hxemophilic but all the daughters will be carriers, and in the next generation half the grandsons and half the grand-daughters will be affected.
Unfortunately there is at present no known method"'of testing potential female carriers to show the presence of haemophilic genes, and until this becomes possible there is little hope of eradicating the disease. Furthermore, true hxemophilia can occur sporadically in children without previous family history. In 1949 Quick & Conway reported that hemophilia had occurred in one of a pair of identical twins.
Sporadic occurrence is probably due to a mutation and means that new hmmophilic males and new female carriers may arise. Some of the Royal Houses of Europe trace their hemophilia back to Queen Victoria and it is possible that such a mutation occurred in her mother. There is an interesting table in a handbook of the Canadian Haemophilia Society (1962) tracing the occurrence of hemophilia in Queen Victoria's descendants. This shows how the condition was transmitted to the Royal Houses of Spain and Russia. It is possible that this haemophilic strain affected the destinies of both these countries.
There are varying degrees of severity in hemophilia, depending on the concentration of Factor VIII in the circulation. A severely affected patient has 0 % of Factor VIII and a mildly affected one has 2-20%. It has been found that for safe surgery 25 % must be continuously present in the blood and therefore even mildly affected patients need full replacement treatment. Mild cases must not be considered as mild risks; the danger to them of bleeding after surgery is as serious as it is for a severely affected patient and sometimes it is even more dangerous because the disease may not have been suspected until bleeding occurs. Some evidence exists that in tonsillectomies a level higher than 25 % is required. There was trouble in one case when the AHG level was just over 40 %. The normal AHG level is 100 %.
The half-life of Factor VIII is only about four--teen hours. Much of the activity therefore is lost very quickly and repeated high dosage is necessary to maintain the level over 25 % (Fig 2) .
In about 50% of all hoemophiliacs there is a special circulating anticoagulant which destroys all the Factor VIII which is given-by injection; these patients cannot undergo any type of surgery with safety. Luckily, the cases are extremely rare, but all haemophiliacs should be tested as a matter of routine for this circulating anticoagulant. (1) Plasma is not potent enough to use for major surgery; after maximum volume transfusions it is unusual to achieve concentrations of AHG of much over 20%; it is useful, however, in cases of minor surgery such as removal of nasal polypi or in cases of epistaxis.
(2) Human AHG is in very short supply and the required dosage may be impossible to obtain; for this reason it is not suitable for adults who of necessity require a large amount; for children however, where the total blood volume is small, human AHG is usually the material of choice.
(3) Animal AHG, which is obtained from pigs or cows, is of high potency and clinically very effective; it should be reserved, if possible, for major surgery. Unfortunately, both pig and bovine AHG are antigenic and can only be given continuously for seven to ten days and for not more than two or three courses during a patient's life. The indication must therefore be exceptional before surgery is undertaken. Human AHG should be used for children in order that the To illustrate replacement therapy, it is necessary to describe in detail a case of tonsillectomy in a hlmophilic male.
Case 1-The patient, aged 36, gave a history of seven quinsies, several of which had burst spontaneously, and they had all been treated with antibiotics. His usual level of AHG was 3 9 %. Two hours before operation he was given pig AHG and at the time of operation the level was 116%. The surgery was difficult, as was to be expected in view of the repeated quinsies, but the blood appeared to clot normally.
In twenty-four hours the level had fallen to 20-5 %. A further infusion raised it to 85 % and it was maintained at about 60% for five days by daily infusion. The level was then allowed to fall to 27 % and by the tenth day it was tailing off to 19 %.
The average volume of animal AHG injected daily was about 425 ml. There were no marked complications although on the sixth day slight bleeding occurred. Hemophiliacs are markedly susceptible to secondary infection and the bleeding could have been called a simple secondary hiemoffhage but, as the tonsillar fossa can never be immobilized, it was thought necessary to control the bleeding by further injections of AHG.
Detailed records have to be kept every day for ten days following operation in order that the haematologist should have a clear picture of the clotting potential at any given time. The work and the man-hours involved for each patient are considerable.
Children become stoical and accept the twice daily vein-puncture, but acceptance depends on the skill and personality of the doctor taking the blood. Confidence can be built up if the same doctor does all vein-punctures and transfusions, a point in favour of treating all patients with hemostatic defects through a centralized and special unit, the personnel of which gain great practical experience in dealing with children needing these daily investigations and treatment. There are also other and more fundamental points in favour of centralization. When surgery is being considered, very detailed and repeated investigations are needed for all cases with blood coagulation defects and it is vitally important that any replacement material which may be necessary should be available before surgery is undertaken. Furthermore, all deficiency factor replacement infusions are in short supply, especially those for rare conditions. If surgery takes place under the supervision of a special unit, replacement material which is not used can be returned, rather than wasted. This is especially true if it is found that a smaller dosage would suffice or that a more easily obtained factor could be substituted'Tor one which has a specific use. Such decisions need expert judgment, but the question of wastage is a very real one, both practically and financially. For example, it is not uncommon to use £250 worth of AHG in certain cases, and as much as £1,000 has been spent on transfusion materials for one patient.
These points and, particularly, the safety of the patient argue that final diagnosis and surgery should take place through a unit where all the necessary facilities are available for investigation and supervision of replacement materials.
At the Radcliffe during the last three years there have been 4 cases of tonsillectomy in himophiliacs. At each successive operation the pattern has become more standardized. The initial tension, in what might have been difficult surgery, has been reduced because both surgical and nursing staff have learnt to accept that the blood will clot in the normal way. The greatest asset, however, when operating on these cases, is patience and, to quote Shakespeare in his anniversary year, to 'make assurance double sure'.
Christmas Disease
Christmas disease is the second most common cause of a clotting defect but the ratio is only one case of Christmas disease to 10 cases of hmmophilia. Together these two conditions account for 96 % of all clotting abnormalities.
The missing substance in Christmas disease is labelled Factor IX. Unfortunately, although the half-life of this factor is slightly longer than that of Factor VIII, it is extremely difficult to raise its level in the blood unless a concentrated solution is prepared; once raised, the level is -somewhat easier to maintain.
The concentrated solution of Factor IX, Christmas factor, is only obtainable in Paris and Oxford; it is extracted from by-products of human blood which would otherwise have been discarded by the Transfusion Services. No surgery should ever be attempted in patients with Christmas disease until an adequate supply of the special concentrate is available. Tonsillectomy in one patient had to be postponed on the day of operation, as the allotted supply of Factor IX had to be used in a more urgent abdominal operation.
Von Willebrand's Disease
There is one family in the area in which 4 out of the 11 children have died, under the age of 3, from repeated epistaxis and other so-called minor bleedings; a fifth child, who is now only 6 years old, already has a sheaf of notes 4 inches thick: this family has Von Willebrand's disease. This horrid condition is due to a double hmmostatic defect. It is not sex linked and is dominantly inherited and thus 50% of the children will be affected. The bleeding is due to poor capillary contraction and also to a hemophilic type of clotting defect. Characteristically there is a long bleeding time and the level of Factor VIII ranges from 0 % to 50 %.
For operations on patients with this disease, hiemostasis must be obtained by pressure to overcome the capillary defect, and the level of AHG must be raised to above 25 % as in a case of true hemophilia. The coagulation defect, however, is different from hmemophilia and it is easier to treat. The difference is that patients with Von Willebrand's disease have the ability to make Factor VIII, but do not do so because their blood lacks some essential stimulating factor. The mechanism can be triggered off by an injection of AHG or, better still, of fibrinogen, which is more readily available (Fig 3) .
After injection the level of AHG will rise and it will not fall steeply over the next twenty-four hours because, in addition to the injection, the patient will start making his own AHG. There will therefore be a tendency for a progressive rise in level on daily treatment. The initial injection Epistaxis is usually a presenting symptom in Von Willebrand's disease and it is very difficult to know what to do. Pressure will usually control the bleeding, and if a large and definite vein is visible it is justifiable to cauterize once, but not more than once, without first discussing the problem with the hvmatologist. Scarring of the tissues may alter the state of the capillaries and cause more prolonged bleeding. Plasma injections will usually help to control the epistaxis when combined with pressure.
Eight patients with Von Willebrand's disease have been seen in the ENT Department of the Radcliffe, and tonsils have been removed in 4 of them. Twenty-six cases have been admitted to other departments in the hospital during the last five years. One of the ENT cases was the following:
Case 2 Girl aged 14 She gave a history of bouts of tonsillitis for eight years and troublesome epistaxis; her mother once had to have 18 pints of blood during a fibroid operation.
After investigation, the patient was diagnosed as having fairly severe Von Willebrand's disease. This meant that, if tonsillectomy were undertaken, the capillary defect could be overcome by pressure, but that the AHG level would have to be raised to overcome the coagulation defect.
The child's level of AHG was about 170% and she had a prolonged bleeding time.
Human AHG was used to raise the level at the time of operation to 60%. Four further injections were given over the next nine days and there was no bleeding during convalescence.
However, a complication did occur: Ten minutes after the operation was due to begin it was reported that the patient had stopped breathing following her injection of Scoline prior to intubation. It was thought unwise to operate until the breathing had started again. This occurred forty-five minutes later, although it might not have started for nine hours if the level of pseudocholinesterase in the blood were low. The operation was carried out with no further trouble. To secure hemostasis' a pack was sewn into each tonsillar fossa and left for twelve hours.
The reason for the period of apnoea was investigated and the pseudocholinesterase in the blood was found to be only 16-5 units per ml. This is much lower than the normal 50-100 units.
This substance is instrumental in the rapid elimination of the Scoline and unless it is present, prolonged apnoea will occur after the injection.
These findings are recorded for two reasons:
(1) Until it is found that there is no connexion be-Section oJ Laryngolugy tween Von Willebrand's disease and a low level of pseudocholinesterase in the blood, all patients with the disease should have this level estimated before operation.
(2) All the other children in the family should be tested in case a similar unpleasant incident should occur if they ever have to undergo a general anxsthesia.
There is no reported connexion between Von Willebrand's disease and a low pseudocholinesterase level and in this case it was probably a coincidence.
Other Coagulation Defects
Prothrombin or Factor II deficiency: There is one family in the area with this deficiency, and details of tonsillectomy on one of them have already been reported (Livingstone & Johnstone 1963) . About 30 % of the members of this family are affected.
Prothrombin is contained in the Christmas factor concentrate and a level of about 40 % by the Oxford method of estimation is needed to secure adequate hemostasis. The half-life of prothrombin is five days and, in tonsillectomies, a second injection is necessary to maintain this level till after the tenth day.
Glanzman's disease: This is a platelet defect. Platelet concentrate is easy to obtain and therefore treatment is comparatively simple. The probable effective duration of the concentrate is also about Five days and two transfusions are required to give the necessary ten days' cover. In one case of tonsillectomy there was bleeding on the fifth day as a second transfusion had not been given.
Summary of Cases with Hamostatic Defects
Tonsillectomy: In the last five years in the ENT Department of the Radcliffe Infirmary, there have been 32 tonsillectomies on patients with capillary defects of varying degrees of severity.
A further 3 cases have been postponed until the indications for surgery become stronger.
In these 32 cases no replacement therapy was needed, but haemostasis was obtained by careful pressure on the site of the operation. On the whole there were no untoward incidents. From 1961 From to 1964 tonsillectomies have been carried out on cases with coagulation defects: 4 of hemophilia, 4 of Von Willebrand's disease and one each of Christmas disease, Glanzman's disease and prothrombin deficiency.
Recently 2 patients with mild hamophilia were operated on. The AHG was over 40% and the hematologist advised that no replacement therapy was indicated, and there were no complications.
Pharyngeal bleeding has occurred in 4 patients with haemophilia: 3 uncomplicated cases and one tracheostomy. The bleeding in these patients was sublingual and in some it had spread into the soft tissues of the neck and around the larynx. In the past, before the isolation of AHG, many cases of this type died from respiratory obstruction. Nowadays this is unlikely to happen because of the security given by AHG replacement and the rapidity with which the bleeding can be controlled.
In patients with pharyngeal haematomata it is wise not to do a tracheostomy. The heematomata resolve very rapidly when the AHG level has been raised to the required percentage, and an endotracheal tube will tide the patient over until the natural airway becomes adequate.
If a tracheostomy is undertaken, full AHG replacement treatment, continuing for ten days, must be given.
One patient who was admitted to the Radcliffe had undergone a tracheostomy at another hospital some hours earlier. This case caused great trouble. While waiting for an accurate blood diagnosis and for the necessary AHG to be given, the patient bled from the tracheostomy into the bronchial tree and a bronchoscopy was necessary to aspirate the blood. A cuffed tube had to be used for two days and the patient had to be given bovine AHG for a full ten days' course.
Because animal AHG is antigenic it may be that one of the patient's opportunities for a safe major operation was taken up by the tracheostomy.
Epistaxis has been dealt with in 20 cases: 11 of hemophilia, 8 of Von Willebrand's disease and one of Factor V deficiency.
In hemophilia, epistaxis is not a usual presenting feature or a great problem; when it does occur a local application of gel foam soaked in plasma should be applied and the AHG level raised by transfusions as soon as is practicable.
Epistaxis is still an important and troublesome symptom in Von Willebrand's disease, especially in children. Pressure over the bleeding point will usually stop the bleeding but it is difficult to do this in infants.
All patients with haemostatic defects and epistaxis should be admitted to hospital.
Conclusion
In conclusion it is necessary once more to stress the following points: In patients with these blood diseases, the indications must be exceptional before surgery is undertaken and pre-operative blood diagnosis is essential; this requires specialist investigations.
Routine screening of all patients awaiting operation is useless as the mild bleeder may show no abnormality; the value of the results that could be obtained by routine blood tests would in no way justify the work involved. The most effective screening test is to take a careful clinical history of bleeding in the patient and in his family. This should be the surgeon's responsibility, and if any definite history of a severe bleeding incident is found the case should be referred for further detailed investigations.
Patients with mild capillary defects present no special problems if hemostasis can be secured by ligature and by local pressure at the site of operation.
Patients with coagulation defects need replacement therapy both before and after operation until healing occurs. Surgery should not be undertaken in patients with coagulation defects until the necessary replacement material is available in adequate quantity and concentration.
It is strongly advocated that the investigations and supervision of the replacement materials and surgery should all take place through a special unit. Probably only three or four special units will be required in the whole country.
